Facebook Linkedin RSS Twitter Youtube
Home 2019

Pediatrics

Skipping the Gym? Blame your Epigenome
News

Skipping the Gym? Blame your Epigenome

Neurocrine Biosciences and Xenon Launch Up-to-$1.7B Epilepsy, Neuroscience Collaboration
Drug Discovery

Neurocrine Biosciences and Xenon Launch Up-to-$1.7B Epilepsy, Neuroscience Collaboration

When Treating HIV Infected Infants, Study Finds Earlier is Better
Featured

When Treating HIV Infected Infants, Study Finds Earlier is Better

Brain Tumors Modeled Using Tunable Extracellular Matrix
Cancer

Brain Tumors Modeled Using Tunable Extracellular Matrix

Sobi Buys Synagis U.S. Rights, Half Share of MEDI18897 U.S. Profits from AstraZeneca
Featured

Sobi Buys Synagis U.S. Rights, Half Share of MEDI18897 U.S. Profits from AstraZeneca

Teratoma-Derived Stem Cells Rebuild Muscle in Model of Muscular Dystrophy
Drug Discovery

Teratoma-Derived Stem Cells Rebuild Muscle in Model of Muscular Dystrophy

Targeting Immature Myeloid Cells to Treat Inflammatory Disorders in Newborns
News

Targeting Immature Myeloid Cells to Treat Inflammatory Disorders in Newborns

Amgen Sues to Reverse FDA Denial of Pediatric Exclusivity for Sensipar
News

Amgen Sues to Reverse FDA Denial of Pediatric Exclusivity for Sensipar

FDA OND Director Jenkins to Retire
Industry News

FDA OND Director Jenkins to Retire

Medgenics, Kyowa Hakko Kirin Partner to Develop Severe Pediatric Onset IBD Candidate
Industry News

Medgenics, Kyowa Hakko Kirin Partner to Develop Severe Pediatric Onset IBD Candidate

123...5Page 2 of 5
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.